Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2026-05-23 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 90% confidence The document is a notice of the outcome of a Board of Directors meeting under SEBI Listing Regulations, detailing the re‐appointment of an Independent Director, Managing Director, and Whole‐Time Director, along with their profiles and terms. It is a corporate announcement of board/management changes, fitting the “Board/Management Information” category.
2026-05-23 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on price movement of the company's stock. It references a regulatory inquiry and states that there is no undisclosed price sensitive information, confirming compliance with SEBI Listing Obligations and Disclosure Requirements. The document is short (1450 characters) and serves as a regulatory communication rather than a financial report or announcement of a report. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents.
2026-04-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, covering the quarter ended 31st March 2026. It certifies details about securities dematerialized/rematerialized during the quarter and confirms that the regulation is not applicable as all shares are in demat form. The document is addressed to the stock exchange and signed by the company secretary and the registrar and share transfer agent. It does not contain financial statements, management discussion, or detailed financial data. It is a compliance certificate related to regulatory requirements rather than a financial report or announcement of financial results. The document length is short (2451 characters), and it is a certification letter. According to the rules, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS).
2026-04-11 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of shares and Takeovers) Regulation, 2011. It confirms that the Promoter and Promoter Group have not made any encumbrance over the shares during the financial year ended 31st March 2026. This is a regulatory disclosure related to shareholding and encumbrance status, not a financial report or announcement of voting results. It fits the category of Major Shareholding Notification (MRQ) as it pertains to disclosures about shareholding and related regulatory compliance under SEBI takeover regulations. The document length is short and it is a formal disclosure letter, not a report or announcement of a report publication.
2026-04-10 English
General Updates
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of the Securities Exchange Board of India (SEBI) (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms that the Promoter and Promoter Group have not made any encumbrance over the shares during the financial year ended 31st March 2026. This type of disclosure relates to changes or confirmations about substantial shareholdings or share encumbrances. It is not a full financial report, audit, or management discussion. It is a regulatory disclosure about shareholding status, which fits the category of Major Shareholding Notification (MRQ). The document length is short and it is a direct disclosure, not an announcement of a report or certification. Therefore, the appropriate classification is MRQ with high confidence.
2026-04-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India regarding the closure of the trading window for insiders due to the upcoming release of the Audited Financial Results for the fiscal year ended March 31, 2026. It is an intimation about trading restrictions and does not contain any financial data, results, or detailed report content. The document is short (1373 characters) and serves as a notification rather than the financial report itself. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance-related communications that do not fit other categories.
2026-03-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.